While 2 out of 3 patients had a CD117 (c-kit gene mutation) positive on immunohistochemical testing, the literature reports that more than 95% of cases carry a c-kit mutation which plays a pivotal role in defining GIST.[9] On the other hand, CD34 was negative in all our patients, although some studies have shown that CD34 is positive in 70% of EGIST cases.[10] The suspicion of EGIST was present on imaging of 2 cases from our series but the confirmation of its presence, in all the cases, was only possible after surgical pathology completion. Here, CD34 is linked to gastrointestinal stromal tumor.